CA 125 is primarily used to monitor the response to treatment in patients with ovarian cancer. It can also be used to detect a recurrence of the disease. Elevated levels of CA 125 may indicate the presence of ovarian cancer, but they can also be elevated in other benign conditions such as endometriosis, menstruation, and pelvic inflammatory disease.
